| Literature DB >> 35100340 |
Elizabeth Tseng1, Jason G Underwood1, Brandon D Evans Hutzenbiler2,3, Shawn Trojahn4, Brewster Kingham5, Olga Shevchenko5, Erin Bernberg5, Michelle Vierra1, Charles T Robbins3,4, Heiko T Jansen2, Joanna L Kelley4.
Abstract
Understanding hibernation in brown bears (Ursus arctos) can provide insight into some human diseases. During hibernation, brown bears experience periods of insulin resistance, physical inactivity, extreme bradycardia, obesity, and the absence of urine production. These states closely mimic aspects of human diseases such as type 2 diabetes, muscle atrophy, as well as renal and heart failure. The reversibility of these states from hibernation to active season enables the identification of mediators with possible therapeutic value for humans. Recent studies have identified genes and pathways that are differentially expressed between active and hibernation seasons in bears. However, little is known about the role of differential expression of gene isoforms on hibernation physiology. To identify both distinct and novel mRNA isoforms, full-length RNA-sequencing (Iso-Seq) was performed on adipose, skeletal muscle, and liver from three individual bears sampled during both active and hibernation seasons. The existing reference genome annotation was improved by combining it with the Iso-Seq data. Short-read RNA-sequencing data from six individuals were mapped to the new reference annotation to quantify differential isoform usage (DIU) between tissues and seasons. We identified differentially expressed isoforms in all three tissues, to varying degrees. Adipose had a high level of DIU with isoform switching, regardless of whether the genes were differentially expressed. Our analyses revealed that DIU, even in the absence of differential gene expression, is an important mechanism for modulating genes during hibernation. These findings demonstrate the value of isoform expression studies and will serve as the basis for deeper exploration into hibernation biology.Entities:
Keywords: Iso-Seq; alternative splicing; brown bear; differential isoform expression; full-length transcript sequencing; hibernation; transcriptomics
Mesh:
Substances:
Year: 2022 PMID: 35100340 PMCID: PMC9210309 DOI: 10.1093/g3journal/jkab422
Source DB: PubMed Journal: G3 (Bethesda) ISSN: 2160-1836 Impact factor: 3.542
Figure 1Bear transcriptome workflow. For each of the six bears, tissues (muscle, liver, and adipose) were extracted during active or hibernation seasons. PacBio Iso-Seq data were collected from three bears and Illumina RNA-seq data were collected from six bears. Iso-Seq data were processed through a pipeline of isoseq3, SQANTI3, and IsoAnnot, before merging with the reference transcriptome to create a merged annotation set to map RNA-seq data using Kallisto. Differential isoform expression and splice junction usage were determined using tappAS.
Figure 2Gene- and isoform-level correlation between Iso-Seq and RNA-seq count data (log cpm). Correlation measured with Pearson correlation. Samples are coded using three letters representing [animal], [tissue], and [season]. The three bears were numbered. The tissues were adipose (A), liver (L), and muscle (M). The seasons were hibernation (H) or active (A).
Figure 3Isoform Classification (A) SQANTI3 isoform classification explanation, FSM, full-splice match; ISM, incomplete-splice match; NIC, novel in catalog; NNC, novel not in catalog. Genic Genomic = overlaps introns and exons. For (B) through (E) Left: PacBio-only. Right: PacBio+Reference Merged dataset. (B) Length distribution of transcripts, shaded by classification. (C) Isoforms per gene. (D) Percentage of predicted NMD by classification. (E) Example of the improved transcriptome by combining existing reference (top, gray) with the PacBio Iso-Seq transcriptome (middle, pink) into a merged (bottom, purple) transcriptome (see also Supplementary Figure S3).
Figure 4Ribosomal RNA depleted RNA-seq data mapped to transcriptomes and the reference genome. Average percentage of reads mapped per season and tissue. Error bars indicate range.
Number and percentage of genes showing DIU and/or major isoform switching between hibernation and active seasons in each tissue
| Adipose | Liver | Muscle | |
|---|---|---|---|
| DIU—major isoform switching | 779 (8.7%) | 201 (2.7%) | 85 (1.6%) |
| DIU—no major isoform switching | 1679 (18.8%) | 379 (5.0%) | 198 (3.7%) |
| Not DIU—major isoform switching | 1196 (13.4%) | 1228 (16.3%) | 826 (15.4%) |
| Not DIU—no major isoform switching | 5268 (59.0%) | 5706 (75.9%) | 4255 (79.3%) |
| Total genes analyzed | 8922 | 7514 | 5364 |
Figure 5Differential isoform expression of ITGB3BP mRNA in adipose tissue. (A) Expression changes at the gene and coding sequence (CDS) level. (B) Short read expression of the two ITGB3BP isoforms across all bears and tissues. (C) Isoform structure of two ITGB3BP isoforms, dashed box indicates the region of the isoforms that differs. (D) Protein alignment (MUSCLE) for the human isoform and the bear isoform observed in the active season. Putative functional motifs based on the human protein co-activator function are shown in bold text. The slash represents the beginning of C-terminal peptide sequence altered by the splicing event observed in hibernating bears. The skipped exon results in a shorter C-terminus shown below the full-length alignments.